Eclampsia clinical trials at UCSD
2 in progress, 1 open to eligible people
Multi-Omics for Maternal Health After Preeclampsia
open to eligible females ages 18-50
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
San Diego, California
MIRACLE of LIFE Study
Sorry, in progress, not accepting new patients
The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question it aims to answer are: 1. Can cell-free RNA-based biomarkers predict which pregnant people are at greatest risk of developing adverse pregnancy outcomes (e.g., preterm birth, preeclampsia)? 2. What is the performance of such biomarkers when predicting an adverse pregnancy outcome (e.g., sensitivity, specificity, PPV, NPV, TPR)?
San Diego, California and other locations
Our lead scientists for Eclampsia research studies include Marni Jacobs, PhD Louise Laurent, MD, PhD.
Last updated: